期刊文献+

肝细胞癌中泛素蛋白表达及其与临床病理学的相关性 被引量:2

A study on the ubiquitin expression and its clinicopathologic significance in hepatocellular carcinoma
下载PDF
导出
摘要 目的探讨肝细胞癌中泛素蛋白表达及其临床病理学意义。方法应用免疫组化方法在组织微阵列上检测泛素蛋白表达,并分析其与临床病理学指标之间相关性。结果肝细胞癌中泛素蛋白表达明显增强,并与肿瘤分级、分型、乙型肝炎病毒感染密切相关(P分别<0.05,0.01和0.05),与患者性别、年龄、肿瘤大小、癌旁状况、AFP水平等指标无相关性(P>0.05)。结论蛋白酶体功能增强是肝细胞癌发生、发展的重要机制,检测肿瘤中泛素蛋白表达可用于指导临床治疗。 Objective To explore the expression status of ubiquitin in hepatocellular carcinoma and its clinicopathologic significance.Method Ubiquitin was detected in tissue microarray by immunohistochemistry,in addition, the relativity between ubiquitin expression and clinicopathologic indexes was analyzed.Results Ubiquitin expression not only was remarkably enhanced in hepatocellular carcinoma, but also correlated with tumor grade, type and HBV infection (P〈0.05, 0.01, 0.05, respectively). No relativity was found between ubiquitin expression and age, gender, tumor size, surrounding tissue, AFP level (P〉0.05).Conclusion A important mechanism in hepatocellular carcinoma occurrence and development is the elevation of proteasome function. Ubiquitin detection would direct clinic therapy in the near future.
机构地区 [
出处 《实用医药杂志》 2005年第8期710-712,共3页 Practical Journal of Medicine & Pharmacy
关键词 肝细胞癌 泛素蛋白 组织微阵列 临床病理学 Hepatocellular carcinoma(HCC) Ubiquitin Tissue microarray(TMA) Clinicopathology
  • 相关文献

参考文献5

二级参考文献74

  • 1Shuang Ping Guo~1 Wen Liang Wang~1 Yu Qiang Zhai~2 Yi Ling Zhao~1 ~1Department of Pathology,Xijing Hospital of the Fourth Military Medical University,Xi’an,China ~2Department of Urology,the Central Hospital of Xi’an,China.Expression of nuclear factor-KB in hepatocellular carcinoma and its relation with the X protein of hepatitis B virus[J].World Journal of Gastroenterology,2001,7(3):340-344. 被引量:55
  • 2方家椿,石永进,彭敬,詹京辉,梁云燕,王代树,王来新,林桂椿,张礼和.8-氯腺苷的抗肿瘤作用研究[J].中华肿瘤杂志,1995,17(1):5-8. 被引量:19
  • 3詹京辉,方家椿,石永进,彭敬,王代树,梁云燕.8-氯腺苷对小鼠肝癌H_(22)细胞的抑瘤作用研究[J].中国药理学通报,1996,12(1):71-73. 被引量:8
  • 4Rivett AJ. The multicatalvtie proteinase. Multiple proteolytic activities [J]. J Biol Chem. 1989, 264-(21 ): 12215 -12219.
  • 5Kisselev AF, Goldberg AL. Proteasome inhibitors: from research tools to drug candidates IJ]. Chem Biol, 2001, 8: 739- 758.
  • 6Teicher BA, Ara G, Herbst R. et al. The proteasome inhibitor PS-341 in cancer therapy [J] . Clin Cancer Res, 1999, 5(9):2638-264-5.
  • 7Lee DH. Goldberg AL. Proteasome inhibitors cause induction of heat shock proteins and trehalose, which together confer thermotolerance in Saccharomyces cerevisiae [J]. Mol Cell Biol,1998. 18(I):30-38.
  • 8Pahl HIJ. Activators and target genes of Rel/NF-kappaB transcription factors [ J ]. Oncogene. 1999, 18 (49) : 6853 - 6866.
  • 9Cho-Chung YS. Role of cyclic 4MP receptor proteins in growth.differentiation, and suppression of malignancy: new approaches to therapy [J]. Cancer Rcs. 1990.50(22): 7093 -7100.
  • 10Valmori D, Gileadi U, Servis C, et al. Modulation of proteasomal activity required for the generation of a cytotoxie T lymphocyte-defined peptide derived from the tumor antigen MAGE-3 [J]. J Exp Med, 1999,189(6): 895 -906.

共引文献48

同被引文献51

引证文献2

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部